ATP-binding Cassette Transporter G1 Deficiency Dysregulates Host Defense in the Lung

Mice with genetic deletion of the cholesterol efflux transporter, ATP-binding cassette (ABC) G1, have pulmonary lipidosis and chronic pulmonary inflammation. Whether ABCG1 regulates host defense is unknown. To determine whether ABCG1 regulates pulmonary innate immunity and host defense, and to inves...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 182; no. 3; pp. 404 - 412
Main Authors DRAPER, David W, MADENSPACHER, Jennifer H, DIXON, Darlene, KING, Debra H, REMALEY, Alan T, FESSLER, Michael B
Format Journal Article
LanguageEnglish
Published New York, NY American Thoracic Society 01.08.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mice with genetic deletion of the cholesterol efflux transporter, ATP-binding cassette (ABC) G1, have pulmonary lipidosis and chronic pulmonary inflammation. Whether ABCG1 regulates host defense is unknown. To determine whether ABCG1 regulates pulmonary innate immunity and host defense, and to investigate the underlying molecular/cellular mechanisms. Abcg1(+/+) and Abcg1(-/-) mice were challenged with intrapulmonary lipopolysaccharide (LPS) or Klebsiella pneumoniae, intravenous K. pneumoniae, or intraperitoneal LPS. Phenotypic responses were profiled. Bone marrow chimeras and in vitro assays were used to differentiate and characterize the role of hematopoietic versus nonhematopoietic ABCG1 in host defense. Unexposed Abcg1(-/-) mice had normal numbers of circulating neutrophils, but increased neutrophil recruitment to the airspace and lung parenchyma, and increased airspace cytokines and chemokines in the steady state. After intrapulmonary LPS or K. pneumoniae, Abcg1(-/-) mice displayed exaggerated further neutrophil recruitment to and degranulation in the airspace, and elevated airspace cytokine/chemokine induction. Alveolar macrophage ABCG1 was critical, as ABCG1 deficiency in hematopoietic cells was sufficient to enhance responses in vivo, and Abcg1(-/-) alveolar macrophages adopted a "foam cell" phenotype, and were hyperresponsive ex vivo. Pulmonary compartmentalization and clearance of K. pneumoniae were increased in Abcg1(-/-) mice, indicating enhanced host defense. By contrast, Abcg1(+/+) and Abcg1(-/-) mice had equivalent responses to intravenous K. pneumoniae and intraperitoneal LPS, suggesting that ABCG1 regulates innate immunity in a tissue-selective manner. Abcg1(-/-) mice have an enhanced pulmonary host defense response driven predominantly by hematopoietic cells.
Bibliography:This article has an online supplement, which is accessible from this issue's table of contents at www.atsjournals.org
Originally Published in Press as DOI: 10.1164/rccm.200910-1580OC on April 15, 2010
Supported in part by Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences grant Z01 ES102005.
Author Disclosure: D.W.D. is an employee of the National Institutes of Health (NIH). J.H.M. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. D.D. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. D.H.K. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. A.T.R. received more than $100,001 from KineMed Inc. for a peptide drug development project–NIH-approved cooperative research agreement (CRADA), $5,001–$10,000 from AlphaCore Pharma for a recombinant Lecithin-cholesterol acyltransferase development project–NIH-approved CRADA, and $5,001–$10,000 from VirxSys Inc. for a trans-splicing gene delivery project–NIH-approved CRADA. M.B.F. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.
ISSN:1073-449X
1535-4970
DOI:10.1164/rccm.200910-1580oc